Jia‐Long Fang Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
faculty
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Jia-Long Fang investigates the mechanisms of chemical toxicity and metabolic disorders. His research includes studies on the carcinogenicity of various dyes and the evaluation of drug safety. Fang has published work on the toxicity of polyethylene glycols in Sprague Dawley rats and the role of the thromboxane A2/thromboxane A2 receptor axis in hepatic insulin resistance and steatosis in non-alcoholic fatty liver disease.
Further research by Fang explores therapeutic interventions for metabolic diseases. This includes investigating how piperlongumine, a natural alkaloid, and ginkgolide B, a compound derived from Ginkgo biloba, can ameliorate metabolic-associated fatty liver disease and glucolipid metabolism disorders, respectively. His work also touches upon the mitigation of oxidative stress and intestinal aging through microbial metabolites, such as indole-3-lactic acid produced by Lactiplantibacillus plantarum.
Fang's scholarly contributions are reflected in his h-index of 29, with over 2,900 citations across 62 publications. He has collaborated with researchers at the National Center for Toxicological Research, including Frederick A. Beland, Mackean P. Maisha, Michelle M. Vanlandingham, and Robert P. Felton.
Metrics
- h-index: 30
- Publications: 65
- Citations: 3,170
Selected Publications
-
NAD(P)+-dependent alcohol oxidoreductases oxidize 7-hydroxycannabidiol to a reactive formyl metabolite (2025)
-
Flow cytometric analysis of the SARS coronavirus 2 antibodies in human plasma (2025)
-
Two-year dermal carcinogenicity bioassay of triclosan in B6C3F1 mice (2023)
-
Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination (2023)
-
Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination (2023)
-
Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats (2022)
Collaboration Network
Top Collaborators
- Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats
- Two-year dermal carcinogenicity bioassay of triclosan in B6C3F1 mice
- NAD(P)+-dependent alcohol oxidoreductases oxidize 7-hydroxycannabidiol to a reactive formyl metabolite
- Flow cytometric analysis of the SARS coronavirus 2 antibodies in human plasma
- Thromboxane A2/thromboxane A2 receptor axis facilitates hepatic insulin resistance and steatosis through endoplasmic reticulum stress in non‐alcoholic fatty liver disease
- Piperlongumine, a natural alkaloid from Piper longum L. ameliorates metabolic-associated fatty liver disease by antagonizing the thromboxane A2 receptor
- Ginkgolide B alleviates glucolipid metabolism disorders and adipose tissue inflammation by inhibiting thromboxane A2 synthesis
- Lactiplantibacillus plantarum CCFM8610 mitigates oxidative stress-related intestinal aging through its metabolite indole-3-lactic acid
- Thromboxane A2/thromboxane A2 receptor axis facilitates hepatic insulin resistance and steatosis through endoplasmic reticulum stress in non‐alcoholic fatty liver disease
- Piperlongumine, a natural alkaloid from Piper longum L. ameliorates metabolic-associated fatty liver disease by antagonizing the thromboxane A2 receptor
- Ginkgolide B alleviates glucolipid metabolism disorders and adipose tissue inflammation by inhibiting thromboxane A2 synthesis
- Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats
- Two-year dermal carcinogenicity bioassay of triclosan in B6C3F1 mice
- Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats
- Two-year dermal carcinogenicity bioassay of triclosan in B6C3F1 mice
- Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats
- Two-year dermal carcinogenicity bioassay of triclosan in B6C3F1 mice
- Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats
- Two-year dermal carcinogenicity bioassay of triclosan in B6C3F1 mice
- Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
- Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
- Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
- Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
- Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
- Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
- Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
- Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
- Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
- Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
- Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
- Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
- Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
- Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
- Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
- Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
Similar Researchers
Based on overlapping research topics